Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 1/21/2026China Launches Clinical Trial of First Acne Vaccine Candidate
  • 1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...
  • 1/21/2026CDE Issues Draft Guidance on Using Bayesian External Data in Drug Clin...
  • 1/21/2026Roche Advances Oral GLP-1 Program as RO7795081 Cleared for China Clini...
  • 1/21/2026Pfizer Pulls Back on Mesothelin-Targeting ADC Sublicensed from Harbour...
  • 1/21/2026NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-AI Drug Develop...
  • 1/21/2026Telix Advances China Strategy as Prostate Cancer Imaging Filing Clears...
  • 1/21/2026Harbour BioMed Takes Strategic Stake in Spruce Biosciences
  • 1/20/2026Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk Seen as Likely Cus...
  • 1/20/2026Ellipses In-Licenses First-in-Class B7H3 ADC from China's Innolake
  • 1/20/2026Insilico and Hygtia Therapeutics Forge Global Alliance on AI-Discovere...
  • 1/20/2026GSK to Buy RAPT Thera for $2.2B, Securing China-Partnered Anti-IgE Ass...
  • 1/19/2026NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guidelines for Drug ...
  • 1/19/2026Biyo Secures ~CNY 100M in Pre-A Funding as Lead Migraine Biologic Adva...
  • 1/19/2026ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...
  • 1/19/2026Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...
  • 1/19/2026AstraZeneca Acquires Full Global Rights to AbelZeta’s GPC3 Armored CA...
  • 1/17/2026Recent Executive Moves
  • 1/16/2026Takeda Submits China Marketing Application for Obretone Tablets
  • 1/16/2026AmCham China Survey Shows Resilience and Improving Performance Among U...
  • 1/16/2026HEC Pharma Wins China Approval for Olorigliflozin in Type 2 Diabetes
  • 1/16/2026China's NMPA to Mandate eCTD Submission Starting March 1
  • 1/16/2026WuXi Biologics and WuXi XDC Launch HK$1.86B Takeover Bid for BioDLink
  • 1/16/2026Exegenesis Files for HKSE IPO to Advance Gene and Oligonucleotide Ther...
  • 1/16/2026Zenitar Files for HKSE IPO Following $87M Series C Raise
  • 1/16/2026Sanofi Gains Approval for Two Innovative Therapies in China
  • 1/16/2026Simcere Zaiming Files for Hong Kong IPO to Accelerate Oncology Pipelin...
  • 1/14/2026Chinese Scientists Unveil Novel Intratumoral Vaccine
  • 1/14/2026Caldera Launches with $112.5 Million to Advance China-Licensed IBD Bs...
  • 1/14/2026Pfizer Announces Completion of Key China Phase 3 Trial for Migraine Dr...
  • Page:1/58 Total number of articles:1738: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group